LU73993A1 - - Google Patents

Info

Publication number
LU73993A1
LU73993A1 LU73993A LU73993A LU73993A1 LU 73993 A1 LU73993 A1 LU 73993A1 LU 73993 A LU73993 A LU 73993A LU 73993 A LU73993 A LU 73993A LU 73993 A1 LU73993 A1 LU 73993A1
Authority
LU
Luxembourg
Application number
LU73993A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU73993A1 publication Critical patent/LU73993A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU73993A 1974-12-13 1975-12-11 LU73993A1 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2458965A DE2458965C3 (de) 1974-12-13 1974-12-13 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU73993A1 true LU73993A1 (cs) 1976-11-11

Family

ID=5933305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU73993A LU73993A1 (cs) 1974-12-13 1975-12-11

Country Status (27)

Country Link
US (1) US4051252A (cs)
JP (1) JPS5182266A (cs)
AT (1) AT343653B (cs)
BE (1) BE836528A (cs)
CA (1) CA1059523A (cs)
CH (1) CH622250A5 (cs)
CS (1) CS189731B2 (cs)
DD (1) DD125484A5 (cs)
DE (1) DE2458965C3 (cs)
DK (1) DK137082C (cs)
ES (1) ES443429A1 (cs)
FI (1) FI753493A7 (cs)
FR (1) FR2293928A1 (cs)
GB (1) GB1490306A (cs)
HK (1) HK52580A (cs)
HU (1) HU173557B (cs)
IE (1) IE42208B1 (cs)
IL (1) IL48642A (cs)
KE (1) KE3078A (cs)
LU (1) LU73993A1 (cs)
NL (1) NL7514521A (cs)
NO (1) NO145382C (cs)
PL (1) PL99858B1 (cs)
SE (1) SE419645B (cs)
SU (1) SU604487A3 (cs)
YU (1) YU315275A (cs)
ZA (1) ZA757777B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431657A (en) * 1982-05-24 1984-02-14 Ayerst, Mckenna & Harrison Inc. Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
KR20010086657A (ko) * 2000-03-02 2001-09-15 성재갑 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
CA2422367C (en) 2000-09-15 2010-05-18 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
ZA200301701B (en) * 2000-09-15 2004-03-01 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors.
US7473691B2 (en) * 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
SI1318997T1 (sl) * 2000-09-15 2006-12-31 Vertex Pharma Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
WO2002059111A2 (en) 2000-12-21 2002-08-01 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
KR100406634B1 (ko) * 2001-03-12 2003-11-20 주식회사 엘지생명과학 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
ES2380054T3 (es) 2001-09-26 2012-05-08 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasas, procedimientos para su preparación, y composiciones farmacéuticas que los contienen
EP2322521B1 (en) * 2002-02-06 2013-09-04 Vertex Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of GSK-3
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
AU2003227741A1 (en) 2002-05-17 2003-12-02 Pharmacia Italia S.P.A. Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MY141867A (en) * 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
JP4733388B2 (ja) 2002-08-02 2011-07-27 バーテックス ファーマシューティカルズ インコーポレイテッド Ｇｓｋ−３のインヒビターとして有用なピラゾール組成物
AU2003270701B2 (en) * 2002-10-31 2009-11-12 Amgen Inc. Antiinflammation agents
WO2004072029A2 (en) 2003-02-06 2004-08-26 Vertex Pharmaceuticals Incorporated Pyrazolopyridazines useful as inhibitors of protein kinases
CN1902193B (zh) * 2003-12-04 2011-07-13 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的喹喔啉
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
AU2006279376B2 (en) 2005-08-18 2011-04-14 Vertex Pharmaceuticals Incoporated Pyrazine kinase inhibitors
BRPI0619706A2 (pt) * 2005-11-03 2011-10-11 Vertex Pharma composto, composição, método para inibir a atividade da proteìna aurora quinase numa amostra biológica, método para tratar um distúrbio proliferativo num paciente, método para tratar cáncer num indivìduo
CN102140081A (zh) * 2006-04-14 2011-08-03 雅培制药有限公司 制备抑制香草素亚型1(vr1)受体的吲唑基脲的方法
MX2009004807A (es) 2006-11-02 2009-06-15 Vertex Pharma Aminopiridinas y aminopirimidinas utiles como inhibidores de proteina cinasa.
EP2099787B1 (en) 2006-12-19 2010-07-21 Vertex Pharmaceuticals, Inc. Aminopyrimidines useful as inhibitors of protein kinases
JP2010520887A (ja) 2007-03-09 2010-06-17 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリジン
JP5393489B2 (ja) 2007-03-09 2014-01-22 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリミジン
JP5520057B2 (ja) 2007-03-09 2014-06-11 バーテックス ファーマシューティカルズ インコーポレイテッド 蛋白キナーゼの阻害剤として有用なアミノピリミジン
NZ580343A (en) 2007-04-13 2012-03-30 Vertex Pharma Aminopyrimidines useful as kinase inhibitors
CA2694381A1 (en) 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
MX2009011810A (es) * 2007-05-02 2010-01-14 Vertex Pharma Tiazoles y pirazoles utiles como inhibidores de cinasa.
CA2688584A1 (en) * 2007-05-02 2008-11-13 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
AU2008257044A1 (en) * 2007-05-24 2008-12-04 Vertex Pharmaceuticals Incorporated Thiazoles and pyrazoles useful as kinase inhibitors
WO2009018415A1 (en) * 2007-07-31 2009-02-05 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
RU2011112802A (ru) * 2008-09-03 2012-10-10 Вертекс Фармасьютикалз Инкорпорейтед (Us) Сокристаллы и содержащие их фармацевтические композиции
DE102009004245A1 (de) 2009-01-09 2010-07-15 Bayer Schering Pharma Aktiengesellschaft Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
BR112015001546B1 (pt) 2012-07-24 2021-02-23 Bial-Portela & Ca, S.A compostos de ureia e sua utilização como inibidores enzimáticos
US20150197503A1 (en) * 2012-07-27 2015-07-16 Bial-Portela & Cª, S.A. Process for the synthesis of substituted urea compounds
AU2014293731B2 (en) 2013-07-24 2018-03-08 Bial - Portela & Ca, S.A. Imidazolecarboxamides and their use as FAAH inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
CH397698A (de) * 1961-09-08 1965-08-31 Siegfried Ag Verfahren zur Herstellung neuer 1-Carbamyl-indazole
US3274203A (en) * 1963-05-31 1966-09-20 Du Pont 1-carbamyl and thiocarbamyl-3-amino-4-nonsubstituted and substituted pyrazoles
NL6707299A (cs) * 1966-07-16 1968-01-17
DE1770649A1 (de) * 1968-06-15 1971-11-11 Bayer Ag Substituierte 3-Amino-indazole

Also Published As

Publication number Publication date
IE42208B1 (en) 1980-06-18
CA1059523A (en) 1979-07-31
SE7513990L (sv) 1976-06-14
AU8717075A (en) 1977-06-09
IE42208L (en) 1976-06-13
ZA757777B (en) 1976-11-24
HU173557B (hu) 1979-06-28
BE836528A (fr) 1976-06-11
ATA939775A (de) 1977-10-15
NO145382C (no) 1982-03-10
CH622250A5 (cs) 1981-03-31
AT343653B (de) 1978-06-12
SU604487A3 (ru) 1978-04-25
YU315275A (en) 1982-02-28
CS189731B2 (en) 1979-04-30
DK137082C (da) 1978-06-19
JPS5182266A (en) 1976-07-19
FR2293928A1 (fr) 1976-07-09
DD125484A5 (cs) 1977-04-20
IL48642A0 (en) 1976-02-29
DK137082B (da) 1978-01-16
PL99858B1 (pl) 1978-08-31
DE2458965B2 (de) 1979-02-22
GB1490306A (en) 1977-11-02
FI753493A7 (cs) 1976-06-14
ES443429A1 (es) 1977-04-16
FR2293928B1 (cs) 1979-09-21
DK567275A (da) 1976-06-14
HK52580A (en) 1980-09-26
SE419645B (sv) 1981-08-17
US4051252A (en) 1977-09-27
KE3078A (en) 1980-10-03
IL48642A (en) 1979-12-30
NO145382B (no) 1981-11-30
DE2458965C3 (de) 1979-10-11
NO754024L (cs) 1976-06-15
DE2458965A1 (de) 1976-06-16
NL7514521A (nl) 1976-06-15

Similar Documents

Publication Publication Date Title
FI753493A7 (cs)
FR2241232B1 (cs)
AU495870B2 (cs)
AU6599874A (cs)
AU7034374A (cs)
AU7138274A (cs)
AU7465874A (cs)
BG19624A1 (cs)
BG19872A1 (cs)
AU480348A (cs)
AU480902A (cs)
AU481001A (cs)
AU481220A (cs)
AU481423A (cs)
AU481544A (cs)
AU481915A (cs)
AU481917A (cs)
AU481934A (cs)
AU482332A (cs)
BE827400A (cs)
BE829575A (cs)
BE829576A (cs)
BE836576A (cs)
BG19488A1 (cs)
AU479777A (cs)